Louise Rodino Klapac Sarepta Therapeutics, Inc. (SRPT) insider trading activity
Louise Rodino Klapac is Head of R&D, CSO of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 72,141 shares of SRPT, which is worth approximately $9.3 Million. The most recent transaction as insider was on Jun 24, 2024, when has been sold 2,182 shares (Common Stock) at a price of $164.64 per share, resulting in proceeds of $359,244. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
72.1K
5.98%
3M change
2.81%
12M change
Total Value Held
$9.3 Million
Louise Rodino-Klapac Transaction History
LR
Louise Rodino Klapac
Head of R&D, CSO
Cambridge, MA